What are Aromatase Inhibitors?

NewsGuard 100/100 Score

Aromatase inhibitors are a class of hormonal agents that form part of the therapy for some types of breast cancer. These agents are available as pills and may be started after initial surgery or radiation therapy.


The aromatase inhibitors include anastrozole (Armidex), letrozole (Femara) and exemastane (Aromasin).

Mechanism of action

The enzyme aromatase works alongside NADPH (nicotinamide adenine dinucleotide phosphate) to convert male hormones or androgens to estrogens. Specifically, androstenedione and testosterone are converted to estrone and estradiol. Aromatase inhibitors prevent the formation of estrogen and thus reduce the estrogen dependent growth of estrogen receptor (ER) positive cancers.


Aromatase inhibitors are useful in women who have already experienced the menopause and have ER-positive tumors. Since postmenopausal women have small and shrunken ovaries that produce low levels of estrogen, use of aromatase inhibitors may further prevent estrogen production and its stimulation of the tumour growth.

However, among premenopausal who have these ER-positive tumours, the ovaries still produce estrogen at levels which mean aromatase inhibitors will not be able to inhibit tumour growth.

Advantages of using aromatase inhibitors

The advantages of using aromatase inhibitors over other hormonal agents such as tamoxifen include a decrease in vaginal discharge, a reduced risk of blood clotting and less risk of womb cancer.

Side effects

The side effects of taking aromatase inhibitors include:

  • Pain in the muscles and joints
  • Osteoporosis, brittle bones and fractures resulting from minor traumas
  • Confusion and memory impairment


The aromatase inhibitors anastrozole and letrozole are similar in their pharmacokinetic properties and both have a dosing schedule of once daily due to a half life (time taken for a the amount of a drug present in the body to become halved) of approximately 48 hours for each of them. The half life of exemestane on the other hand, is 24 hours.

Further Reading

Last Updated: Jan 20, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, January 20). What are Aromatase Inhibitors?. News-Medical. Retrieved on April 22, 2024 from https://www.news-medical.net/health/What-are-Aromatase-Inhibitors.aspx.

  • MLA

    Mandal, Ananya. "What are Aromatase Inhibitors?". News-Medical. 22 April 2024. <https://www.news-medical.net/health/What-are-Aromatase-Inhibitors.aspx>.

  • Chicago

    Mandal, Ananya. "What are Aromatase Inhibitors?". News-Medical. https://www.news-medical.net/health/What-are-Aromatase-Inhibitors.aspx. (accessed April 22, 2024).

  • Harvard

    Mandal, Ananya. 2023. What are Aromatase Inhibitors?. News-Medical, viewed 22 April 2024, https://www.news-medical.net/health/What-are-Aromatase-Inhibitors.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
DASH diet may lower the risk of cardiovascular disease in breast cancer survivors